Home NDC 63629-1369-8 AMITRIPTYLINE HYDROCHLORIDE
Product NDC 63629-1369
Requested package NDC 63629-1369-8
11-digit product format 636291369
Labeler code 63629
Product ID 63629-1369_8d720a85-1135-4a34-9e56-381b39c28fb9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Amitriptyline Hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Bryant Ranch Prepack
Application ANDA085966
Marketing category ANDA
Marketing start 1977-11-21
Marketing end 0000-00-00
Substance AMITRIPTYLINE HYDROCHLORIDE
Active strength 25 mg/1
Pharmacologic classes Tricyclic Antidepressant [EPC]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2020-12-18 03:04 UTC · source 2020-12-17 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 I Inactivated by FDA 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog .
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2019-12-13 00:20 UTC 2019-12 A085966-001 AMITRIPTYLINE HYDROCHLORIDE 25MG TABLET / ORAL AB RS, Approved before 1982 74a2ff9319b5…2019-12-14 00:12 UTC 2019-12 A085966-001 AMITRIPTYLINE HYDROCHLORIDE 25MG TABLET / ORAL AB RS, Approved before 1982 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A085966-001 AMITRIPTYLINE HYDROCHLORIDE 25MG TABLET / ORAL AB RS, Approved before 1982 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A085966-001 AMITRIPTYLINE HYDROCHLORIDE 25MG TABLET / ORAL AB RS, Approved before 1982 ea99ee380514…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 63629-1369-0 2021-01-06 Amitriptyline Hydrochloride Tablets, USP 63629-1369-1 2021-01-06 Amitriptyline Hydrochloride Tablets, USP 63629-1369-2 2021-01-06 Amitriptyline Hydrochloride Tablets, USP 63629-1369-3 2021-01-06 Amitriptyline Hydrochloride Tablets, USP 63629-1369-4 2021-01-06 Amitriptyline Hydrochloride Tablets, USP 63629-1369-5 2021-01-06 Amitriptyline Hydrochloride Tablets, USP 63629-1369-6 2021-01-06 Amitriptyline Hydrochloride Tablets, USP 63629-1369-7 2021-01-06 Amitriptyline Hydrochloride Tablets, USP 63629-1369-8 2021-01-06 Amitriptyline Hydrochloride Tablets, USP 63629-1369-9 2021-01-06 Amitriptyline Hydrochloride Tablets, USP 63629-1369-0 2019-11-27 Amitriptyline Hydrochloride Tablets, USP 63629-1369-1 2019-11-27 Amitriptyline Hydrochloride Tablets, USP 63629-1369-2 2019-11-27 Amitriptyline Hydrochloride Tablets, USP 63629-1369-3 2019-11-27 Amitriptyline Hydrochloride Tablets, USP 63629-1369-4 2019-11-27 Amitriptyline Hydrochloride Tablets, USP 63629-1369-5 2019-11-27 Amitriptyline Hydrochloride Tablets, USP 63629-1369-6 2019-11-27 Amitriptyline Hydrochloride Tablets, USP 63629-1369-7 2019-11-27 Amitriptyline Hydrochloride Tablets, USP 63629-1369-8 2019-11-27 Amitriptyline Hydrochloride Tablets, USP 63629-1369-9 2019-11-27 Amitriptyline Hydrochloride Tablets, USP
DailyMed Socrata Ingredients# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 63629-1369-8 63629136908 28 TABLET, FILM COATED in 1 BOTTLE (63629-1369-8) 1977-11-21 0000-00-00 No No Current